Due to a relatively small number of bViV patients (bail-out rate of only one to two percent) the differences in secondary endpoints did not reach statistical significance, so the observed effects could be underestimated.
1
—
—
Due to a relatively small number of bViV patients (bail-out rate of only one to two percent) the differences in secondary endpoints did not reach statistical significance, so the observed effects could be underestimated.